Skip to content
10-K

Annual Report

Odonate Therapeutics, Inc.

0001564590-21-007296

← back to feed
Filed
Feb 23, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Feb 8, 2021 38.6M sh
Stock Issued FY 2020 · Dec 31, 2020 842.11K sh
Stock Issued FY 2020 · Sep 1, 2020 5.61M sh
Stock Issued FY 2020 · Jul 2, 2019 712.5K sh
Stock Issued FY 2020 · Jun 28, 2019 4.75M sh
Capex FY 2020 · Dec 31, 2020 $432K
Capex FY 2020 · Dec 31, 2019 $166K
Operating Cash Flow FY 2020 · Dec 31, 2020 −$113.13M
Operating Cash Flow FY 2020 · Dec 31, 2019 −$96.64M
Cash And Equivalents FY 2020 · Dec 31, 2020 $157.98M
Cash And Equivalents FY 2020 · Dec 31, 2019 $181.17M
Cash And Equivalents FY 2020 · Dec 31, 2018 $139.3M
Stockholders Equity FY 2020 · Dec 31, 2020 $136.15M
Stockholders Equity FY 2020 · Dec 31, 2019 $162.3M
Stockholders Equity FY 2020 · Dec 31, 2018 $124M
Current Liabilities FY 2020 · Dec 31, 2020 $27.07M
Current Liabilities FY 2020 · Dec 31, 2019 $24.78M
Total Liabilities FY 2020 · Dec 31, 2020 $31.74M
Total Liabilities FY 2020 · Dec 31, 2019 $26.53M
Current Assets FY 2020 · Dec 31, 2020 $159.87M
Current Assets FY 2020 · Dec 31, 2019 $183.93M
Total Assets FY 2020 · Dec 31, 2020 $167.89M
Total Assets FY 2020 · Dec 31, 2019 $188.83M
Sga Expense FY 2020 · Dec 31, 2020 $10.39M
Sga Expense FY 2020 · Dec 31, 2019 $10.9M
Rd Expense FY 2020 · Dec 31, 2020 $117.04M
Rd Expense FY 2020 · Dec 31, 2019 $104.03M
Net Income FY 2020 · Dec 31, 2020 −$126.35M
Net Income FY 2020 · Dec 31, 2019 −$111.83M
Operating Income FY 2020 · Dec 31, 2020 −$127.43M
Operating Income FY 2020 · Dec 31, 2019 −$114.93M